Drug Profile
Mitiglinide/voglibose - Kissei Pharmaceutical/Takeda
Alternative Names: Glubes; KMV-0207; Voglibose/mitiglinideLatest Information Update: 17 Jun 2019
Price :
$50
*
At a glance
- Originator Kissei Pharmaceutical; Takeda
- Class Inositol phosphates; Isoindoles; Small molecules; Sugar alcohols
- Mechanism of Action Alpha-glucosidase inhibitors; Insulinotropin agonists; Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus